Not All Obesity Looks the Same: A New Classification Could Change Who Gets Surgery, and When

Dek: A new international study applying the 2025 Lancet Commission's "clinical obesity" framework to more than 2,300 bariatric surgery patients found that nearly three-quarters had measurable organ damage from their weight — despite having the same BMI as patients without it. (JAMA Network Open, 2026)

For as long as I have been operating on patients with obesity, I have relied on body mass index (BMI) as the first number I look at — and so has almost every insurance company, surgical guideline, and referral letter I receive. But anyone who has sat across from two patients with the exact same BMI knows they can be very different people. One walks into my clinic with well-controlled blood pressure and normal joints. The other, at the same weight, already has heart strain, sleep apnea, and knees that are wearing out. BMI alone cannot tell these two patients apart, and for years that has bothered me clinically. A study published in 2026 in JAMA Network Open finally puts numbers behind what many of us in bariatric surgery have long suspected.

A New Way of Defining Obesity

In 2025, the Lancet Commission on Clinical Obesity proposed a shift away from BMI-only diagnosis toward a two-tier framework: "clinical obesity," where excess body fat is already causing measurable organ or tissue dysfunction (such as heart, joint, kidney, or metabolic damage), and "preclinical obesity," where excess fat is present but organ function is still preserved. This matters because it treats obesity less like a single category and more like a spectrum of actual illness severity — closer to how we think about, say, chronic kidney disease or liver fibrosis.

What the Study Did

Researchers, led by a team including Professor Francesco Rubino, applied this new framework retrospectively to 2,316 patients who had already undergone gastric bypass or sleeve gastrectomy across bariatric centers in the United Kingdom, France, Spain, and Brazil. The goal was simple: see how many real-world surgical patients would actually be classified as having "clinical obesity" versus "preclinical obesity," and whether that classification lined up with anything clinically meaningful.

What They Found

Across the pooled cohort, 73.8% of patients met criteria for clinical obesity, while 26.2% were classified as preclinical — despite very similar average BMI between the two groups at several sites (for example, 47.5 versus 48.5 in the UK cohort). In other words, BMI alone did not distinguish the sicker patients from the healthier ones. What did differ was clinically important: patients with clinical obesity were, on average, roughly a decade older, carried a heavier burden of cardiovascular risk factors, and — in the French cohort specifically — experienced major 30-day surgical complications far more often than preclinical patients (4.0% versus 1.1%).

Why This Matters for Surgical Decision-Making

I want to be careful not to overstate a single study. This was a retrospective analysis, not a randomized trial, and it does not tell us that preclinical-obesity patients should be denied surgery, or that clinical-obesity patients should always be rushed to the operating room. What it does suggest is something more useful in daily practice: BMI should be the starting point of an obesity evaluation, never the whole story. A thorough preoperative work-up — cardiac risk assessment, metabolic panel, sleep study where indicated, joint and functional assessment — tells us far more about a patient's actual risk and potential benefit from surgery than the number on the scale ever could.

This also has implications beyond the operating room. Health systems and insurers that use BMI cutoffs alone to decide who "qualifies" for bariatric surgery or anti-obesity medication may be both under-treating high-risk preclinical patients who are heading toward organ damage, and over-simplifying the urgency for some clinical-obesity patients who need more intensive perioperative optimization, not less access.

The Bottom Line

If you are considering bariatric surgery, your BMI matters, but it is not the full clinical picture. Two people with identical BMI can carry very different surgical risk and very different reasons to act sooner rather than later. This is precisely why a proper surgical evaluation looks well beyond the scale — and why I would encourage any patient, and any referring physician, to think of obesity treatment decisions in terms of overall health impact, not a single number.

Medical disclaimer: This article is for general education only and does not replace a personal consultation, diagnosis, or treatment plan. Always discuss your individual situation with your doctor.